Objective B-cell activating factor (BAFF) is essential for B-cell survival and innate immune activation, and its ...

Background Cardiovascular disease and osteoarthritis (OA) share risk factors, but the link between comprehensive ...

Objectives To evaluate the long-term outcomes, clinical phenotypes and factors associated with complications in Still’s ...

Objectives Owing to the underrepresentation of early-stage disease in randomised trials and inconsistent clinical evidence, ...

Objectives Smoking is recognised as one of the strongest environmental risk factors for the development of rheumatoid ...

Over the last decade, the outlook for patients with rheumatoid arthritis (RA) has improved, but there is growing interest in ...

Objective To understand (1) what guidance exists to assess the methodological quality of qualitative research; (2) what methods exist to grade levels of evidence from qualitative research to inform ...

Objectives Nerandomilast, a selective phosphodiesterase 4B (PDE4B) inhibitor, has been extensively investigated for the treatment of pulmonary fibrosis; however, its therapeutic potential and ...

Objectives To identify glucocorticoid (GC) treatment patterns in patients with polymyalgia rheumatica (PMR) and explore patient profiles that may benefit from GC-sparing interventions. Methods This ...

Background Bimekizumab (BKZ), a monoclonal IgG1 antibody that selectively inhibits interleukin (IL)-17F in addition to IL-17A, has demonstrated 2-year efficacy in non-radiographic axial ...

Background Psoriatic arthritis (PsA) is a multifaceted condition with a broad spectrum of manifestations and a range of associated comorbidities. A notable segment of patients with PsA remains ...